Inicio・Lista de Acciones・OPKO Health Inc

OPKO Health Inc

Cerrado

SectorSanidad

1.37 3.79

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.3599999999999999

Máximo

1.4

Métricas clave
By Trading Economics
Ingresos	46M -8.4M
Ventas	39M 164M
BPA	-0.01
Margen de beneficios	-5.145
Empleados	2,275
EBITDA	40M 12M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+118.98% upside

Dividendos
By Acuity
Próximas Ganancias	28 oct 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	72M 978M
Apertura anterior	-2.42
Cierre anterior	1.37

Noticias sobre sentimiento de mercado

By Acuity

67%

33%

287 / 340 Clasificación en Healthcare

OPKO Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ago 2026, 23:01 UTC

OPKO Health shares advanced in after-market trading, recovering from earlier losses amid broader market dynamics and a slight decline in the unemployment rate.

6 ago 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid notable volatility, with economic data showing initial jobless claims rose slightly ahead of tomorrow's non-farm payrolls report.

5 ago 2026, 23:01 UTC

OPKO Health shares are lower in after-market hours, reflecting broader market weakness amid recent economic data showing weaker-than-expected U.S. job growth.

4 ago 2026, 23:06 UTC

OPKO Health Inc. shares are higher in after-market trading, settling with a cumulative gain following a brief dip at the session's start.

3 ago 2026, 23:01 UTC

OPKO Health Inc shares increased in after-market trading, maintaining a steady rise since Monday's close amid a generally positive market backdrop.

31 jul 2026, 19:45 UTC

OPKO Health Inc. shares are trading roughly flat today, hovering around the middle of their one-month range and above the 20-day moving average.

30 jul 2026, 23:11 UTC

OPKO Health Inc. shares are lower in after-market hours, continuing a recent trend amid broader market uncertainty following the Federal Reserve's interest rate decision.

29 jul 2026, 23:46 UTC

No specific news was identified for OPKO Health Inc. Shares remained roughly flat during after-market hours, trading near unchanged since Wednesday's close.

28 jul 2026, 23:41 UTC

News

OPKO Health reported a narrowed net loss of $8.4 million and raised revenue guidance, but shares are lower in after-market hours following recent gains.

27 jul 2026, 23:41 UTC

News

OPKO Health reported second-quarter revenues of $163.5 million, surpassing expectations. The company also raised its full-year sales guidance, boosting shares in after-market trading.

24 jul 2026, 22:06 UTC

OPKO Health Inc shares are higher in after-market trading, reaching a peak shortly after the market closed. No specific news was identified for this movement.

22 jul 2026, 18:31 UTC

OPKO Health is declining today, having pulled back from earlier gains amid broader market volatility and rising geopolitical tensions.

21 jul 2026, 22:56 UTC

No specific news was identified for OPKO Health during after-market hours. The stock remains roughly flat, positioned 12.60% below its 20-day moving average.

20 jul 2026, 19:51 UTC

OPKO Health Inc shares are higher in Monday's session, reflecting positive trading conditions. Broader market dynamics are supported by strength in Asian markets.

Comparación entre iguales

Cambio de precio

OPKO Health Inc previsión

Precio Objetivo

By TipRanks

118.98% repunte

Estimación a 12 Meses

Media 3 USD 118.98%

Máximo 3 USD

Mínimo 3 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para OPKO Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para OPKO Health Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

287 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.